(25R)-3beta-{O-alpha-L-Rhamnopyranosyl-(1→2)-[O-beta-D-glucopyranosyl-(1→4)-O-alpha-L-rhamnopyranosyl-(1→4)]-beta-D-glucopyranosyl}-22alpha-N-spirosol-5-ene - Compound Card

(25R)-3beta-{O-alpha-L-Rhamnopyranosyl-(1→2)-[O-beta-D-glucopyranosyl-(1→4)-O-alpha-L-rhamnopyranosyl-(1→4)]-beta-D-glucopyranosyl}-22alpha-N-spirosol-5-ene

Select a section from the left sidebar

(25R)-3beta-{O-alpha-L-Rhamnopyranosyl-(1→2)-[O-beta-D-glucopyranosyl-(1→4)-O-alpha-L-rhamnopyranosyl-(1→4)]-beta-D-glucopyranosyl}-22alpha-N-spirosol-5-ene

Structure
Zoomed Structure
  • Family: Plantae - Solanaceae
  • Kingdom: Plantae
  • Class: Steroid
    • Subclass: Glycosidic Steroidal Alkaloid
Canonical Smiles OC[C@H]1OC(OC2CCC3(C(=CCC4C3CCC3(C4CC4C3C(C)C3(O4)CCC(CN3)C)C)C2)C)[C@@H]([C@H]([C@@H]1OC1O[C@H](C)[C@H]([C@@H]([C@@H]1O)O)OC1O[C@H](CO)[C@H]([C@@H]([C@H]1O)O)O)O)OC1O[C@H](C)[C@H]([C@@H]([C@@H]1O)O)O
InChI InChI=1S/C51H83NO20/c1-20-9-14-51(52-17-20)21(2)32-29(72-51)16-28-26-8-7-24-15-25(10-12-49(24,5)27(26)11-13-50(28,32)6)66-48-44(71-45-38(60)35(57)33(55)22(3)64-45)41(63)43(31(19-54)68-48)70-46-40(62)37(59)42(23(4)65-46)69-47-39(61)36(58)34(56)30(18-53)67-47/h7,20-23,25-48,52-63H,8-19H2,1-6H3/t20?,21?,22-,23-,25?,26?,27?,28?,29?,30-,31-,32?,33-,34-,35+,36+,37-,38+,39-,40+,41+,42-,43-,44-,45?,46?,47?,48?,49?,50?,51?/m1/s1
InChIKey MJTVVRUDYJNHJC-SZAVSVHQSA-N
Formula C51H83NO20
HBA 21
HBD 12
MW 1030.21
Rotatable Bonds 10
TPSA 317.63
LogP -1.36
Number Rings 10
Number Aromatic Rings 0
Heavy Atom Count 72
Formal Charge 0
Fraction CSP3 0.96
Exact Mass 1029.55
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Solanum aculeastrum Solanaceae Plantae 329759

Showing of synonyms

  • Wanyonyi AW, Tarus PK, et al. (2003). A novel glycosidic steroidal alkaloid from Solanum aculeastrum. Bulletin of the Chemical Society of Ethiopia,2003,17(1),61-66. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: N1CCCCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CC(CC6)OC(C7OC8CCCCO8)OCC(C7)OC(OC9)CCC9OC1CCCCO1

Level: 4

Mol. Weight: 1030.21 g/mol

Structure

SMILES: N1CCCCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CC(CC6)OC(OC7)CCC7OC(OC8)CCC8OC9CCCCO9

Level: 3

Mol. Weight: 1030.21 g/mol

Structure

SMILES: N1CCCCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CC(CC6)OC(C7OC8CCCCO8)OCC(C7)OC9CCCCO9

Level: 3

Mol. Weight: 1030.21 g/mol

Structure

SMILES: O1CCCCC1OC(COC2)CC2OC(OC3)CCC3OC4CCCCO4

Level: 3

Mol. Weight: 1030.21 g/mol

Structure

SMILES: N1CCCCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CC(CC6)OC(OCCC7)C7OC8CCCCO8

Level: 2

Mol. Weight: 1030.21 g/mol

Structure

SMILES: N1CCCCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CC(CC6)OC(OC7)CCC7OC8CCCCO8

Level: 2

Mol. Weight: 1030.21 g/mol

Structure

SMILES: O1CCCCC1OC2CCC(OC2)OC3CCCOC3

Level: 2

Mol. Weight: 1030.21 g/mol

Structure

SMILES: O1CCCCC1OC2CC(COC2)OC3CCCCO3

Level: 2

Mol. Weight: 1030.21 g/mol

Structure

SMILES: N1CCCCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CC(CC6)OC7CCCCO7

Level: 1

Mol. Weight: 1030.21 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1030.21 g/mol

Structure

SMILES: N1CCCCC12CC3C4C(CC3O2)C5C(CC4)C6C(=CC5)CCCC6

Level: 0

Mol. Weight: 1030.21 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 1030.21 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.62
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
151156.25
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
19755208.48

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.75
Plasma Protein Binding
38.05
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
0.69
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-459454.38
Biodegradation
Safe
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-1.17
Liver Injury II
Safe
hERG Blockers
Safe
Daphnia Maga
4.05
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-35854749509.51
Rat (Acute)
3.75
Rat (Chronic Oral)
76.87
Fathead Minnow
45258975.12
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
4032661541.25
Hydration Free Energy
-2.92
Log(D) at pH=7.4
-2231.6
Log(P)
1.07
Log S
-2.5
Log(Vapor Pressure)
-132793319.26
Melting Point
246.36
pKa Acid
-967519.31
pKa Basic
-7766.1

No predicted protein targets found for this compound.

Download SDF